Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT00973050
Brief Summary:
The objective of this study is to compare the rate and extent of absorption of bicalutamide 50 mg tablets (test) versus Casodex® (reference) administered as 1 x 50 mg tablet under fasting conditions.
Detailed Description:
This will be a single center, bioequivalence, open-label, randomized, 1-way parallel study.
According to the BA/BE guidances, a parallel study is acceptable for drugs with a long half-life.
Study:
NCT00973050
Study Brief:
Protocol Section:
NCT00973050